Drug Profile

Research programme: serotonin 2A/C receptor agonists - Bright Minds Biosciences

Alternative Names: 5-HT2A/C agonists receptor agonists - Bright Minds Biosciences

Latest Information Update: 28 Mar 2025

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Bright Minds Biosciences
Class Non-opioid analgesics
Mechanism of Action 5-HT2C serotonin receptor agonists; Serotonin 5-HT2A receptor agonists

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity Yes

28 Mar 2025 No recent reports of development identified for preclinical development in Pain in Canada
05 Feb 2021 Bright Minds Biosciences and National Institutes of Health (USA) agree to co-develop serotonin 2A/C receptor agonists for Pain
05 Feb 2021 Bright Minds Biosciences has patent protection for psychedelic compounds

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com